Ectosan Vet
Commercial- Indications
- Sea lice in salmon
Company intelligence / Profile preview
Benchmark Holdings plc
United Kingdombenchmarkplc.com ↗
- Ownership
- Private
- Employees
- ~800
- Development stage
- Commercial
01
Overview
Successfully launched Ectosan®Vet and CleanTreat® in Norway in 2021, adding to existing Salmosan®Vet product
- Therapeutic areas
- Other
- Modalities
- Advanced nutrition productsHealth treatmentsEnvironmental solutions
- Industry
- Veterinary
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Institute of Marine Research in BergenNofima AsThe Roslin InstituteUniversity of Iceland
Beyond the preview
Go deeper on Benchmark Holdings plc.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Benchmark Holdings plc.